Vernon Ingram

From Wikipedia, the free encyclopedia

Vernon M. Ingram

Born 19 May 1924
Breslau, Germany
Died 17 August 2006
Boston, Massachusetts
Residence Germany, United Kingdom, United States
Nationality German
Field Biologist
Institution MIT
Alma mater University of London
Academic advisor Fred Barrow

Vernon M. Ingram FRS (19 May 1924 — 17 August 2006) was a German American professor of biology at the Massachusetts Institute of Technology.

Contents

[edit] Biography

Ingram was born in Breslau, Lower Silesia. When he was 14, he and his family left Nazi Germany because of their opposition to Nazism and settled in England.

During the Second World War, Ingram worked at a chemical factory producing drugs for the war effort and at night studied at Birkbeck College at the University of London. He received a bachelor's degree in chemistry in 1945 and a PhD in organic chemistry in 1949.

After receiving his doctorate, Ingram worked at postdoctoral appointments at the Rockefeller Institute and Yale University. At Rockefeller, he worked with Moses Kunitz on crystallizing proteins. While at Yale, he studied peptide chemistry with Joseph Fruton. In 1952, Ingram returned to England and started working at the Cavendish Laboratory at the University of Cambridge, studying protein chemistry.

In 1956 Ingram and John A. Hunt determined that the change in the hemoglobin molecule in sickle cell disease and trait was the substitution of the glutamic acid in position 6 of the β-chain of the normal protein by valine. Ingram used electrophoresis and chromatography to show that the amino acids of normal human and sickle cell anemia hemoglobins differed due to a single mutated gene. Much of this work was done with the support of Max Perutz and Francis Crick.

This was the first time a researcher demonstrated that a single amino acid exchange in a protein can cause a disease or disorder. As a result, Vernon Ingram is sometimes referred to as the "The father of Molecular Medicine." [1]

Ingram joined the MIT faculty in 1958, intending to stay for only one year. He found that he enjoyed it there so much that he stayed on. While at MIT, Ingram collaborated with Paul Marks of Columbia University on hemoglobin research. He was also interested in embryonic hemoglobin and how it differed from that of adults.

By the 1980s, Ingram became interested in neuroscience and especially Alzheimer's Disease. His interest was sparked by the work his second wife, Elizabeth (Beth), was doing with mentally retarded people in the Boston area. She had heard that Down's Syndrome was a disease of the neurofilaments; this turned out not to be the cause, but it was noted that people with Down's Syndrome did develop Alzheimer's Disease by the time they were 40.

After retirement, Ingram continued his research, maintaining a small laboratory at MIT. He and his wife, Beth, were housemasters of Ashdown House at MIT for 16 years. Asteroid 6285 Ingram is named in their honor. [2] He was elected to the National Academy of Sciences in 2002. [3]

Ingram died in Boston, Massachusetts, on August 17, 2006 of injuries stemming from a fall.

[edit] Selected publications

  • Ingram, V.M. (1956). "A Specific Chemical Difference between Globins of Normal and Sickle-cell Anemia Hemoglobins". Nature 178: 792-794. 
  • Ingram,, V.M. (1957). "Gene Mutations in Human Hemoglobin: The Chemical Difference between Normal and Sickle Hemoglobin". Nature 180: 326-328. 
  • Hunt, J.A.; V.M. Ingram (1958). "Abnormal Human Haemoglobins. II. The Chymotryptic Digestion of the Trypsin-resistant Core of Haemoglobins A and S.". Biochimica et Biophysica Acta 28 (3): 46–549. 
  • Ingram, V.M. (1961-03-04). "Gene Evolution and the Hæmoglobins". Nature 189: 704-708. DOI:10.1038/189704a0. 
  • Blanchard, B.J.; A. Chen, C. Kelly, K. Stafford, B. Stockwell & V.M. Ingram (2004). "Novel Compounds eliminate the Neurotoxicity of the Alzheimer Aß Peptide", Abstr. Massachusetts Alzheimer’s Disease Research Center, Annual meeting. 
  • Ingram, V.M.; B.J. Blanchard, A. Chen, C. Kelly, K. Stafford & B. Stockwell (2004). "Blocking the Initial Molecular Mechanism of Alzheimer’s Disease", Abstr. International Congress on Alzheimer’s Disease, Philadelphia. 
  • Ingram, V.M. (2004). "Sickle Cell Anemia hemoglobin: The Molecular Biology of the First ‘Molecular Disease’". Genetics 167: 1-7. 
  • Ingram, V.M. (2004). "The Role of Alzheimer Aß Peptides in Ion Transport across Cell Membranes, in Subcellular Biochemistry: Alzheimer’s Disease", in eds. Harris, R., Fahrenholz, F.: Cellular and Molecular Aspects of Amyloid. London: Kluwer Academic/Plenum Publishers. 
  • Colby, D.W.; P. Garg, G. Chao, J. Webster, A. Messer, V.M. Ingram and K.D. Wittrup (17 Sep 2004). "Development of a Human Variable Light Chain Domain Intracellular Antibody against Huntingtin via Yeast Surface Display". J. Mol. Biol. 342 (3): 901-12. 
  • Webster, J.M.; D.W. Colby, V.M. Ingram, K.D. Wittrup and A. Messer (November 2004). "Enhanced anti-Huntington’s Disease Intrabodies". Abstract Soc. Neurosci.. 
  • Blanchard, B.J.; A. Chen, K. Stafford, P. Weigele and V.M. Ingram (5 Oct 2004). "Efficient Reversal of Alzheimer Fibril Formation and Elimination of Neurotoxicity by a Small Molecule". Proc Natl Acad Sci USA 101 (40): 14326-32. 

Inaugural Article: Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule Barbara J. Blanchard, Albert Chen, Leslie M. Rozeboom, Kate A. Stafford, Peter Weigele, and Vernon M. Ingram PNAS 2004 101: 14326-14332

[edit] See also

[edit] External links

  • Davis, Tinsley H. (2004-10-05). "Biography of Vernon M. Ingram". Proceedings of the National Academy of Sciences of the United States of America 101 (40): 14323-14325. 
Retrieved from "http://en.wikipedia.org../../../v/e/r/Vernon_Ingram_165e.html"